Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Hamblin

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Leukemia Research|October 22, 2008
Non-hemic autoimmunity in CLLTerry J Hamblin
Leukemia Research|October 5, 2007
Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?Terry J Hamblin
BMJ (Clinical Research Ed.)|November 5, 2008
Complementary medicine . Inconsistency over paymentTerry J Hamblin
Leukemia Research|August 16, 2011
Searching for surrogates for IGHV mutations in chronic lymphocytic leukemiaTerry J Hamblin
Leukemia Research|August 23, 2005
Richter's syndrome--the downside of fludarabine?Terry J Hamblin
The New England Journal of Medicine|August 27, 2004
Predicting Progression--ZAP-70 in CLLTerry J Hamblin
Seminars in Oncology|April 18, 2006
Autoimmune complications of chronic lymphocytic leukemiaTerry J Hamblin
Blood|June 25, 2008
Ligandless receptors find a roleTerry J Hamblin
Nature Clinical Practice. Oncology|January 21, 2009
Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men?Terry J Hamblin
Leukemia Research|September 4, 2009
The TCL1 mouse as a model for chronic lymphocytic leukemiaTerry J Hamblin
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Leukemia Research|October 22, 2008
Non-hemic autoimmunity in CLLTerry J Hamblin
Leukemia Research|October 5, 2007
Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?Terry J Hamblin
BMJ (Clinical Research Ed.)|November 5, 2008
Complementary medicine . Inconsistency over paymentTerry J Hamblin
Leukemia Research|August 16, 2011
Searching for surrogates for IGHV mutations in chronic lymphocytic leukemiaTerry J Hamblin
Leukemia Research|August 23, 2005
Richter's syndrome--the downside of fludarabine?Terry J Hamblin
The New England Journal of Medicine|August 27, 2004
Predicting Progression--ZAP-70 in CLLTerry J Hamblin
Seminars in Oncology|April 18, 2006
Autoimmune complications of chronic lymphocytic leukemiaTerry J Hamblin
Blood|June 25, 2008
Ligandless receptors find a roleTerry J Hamblin
Nature Clinical Practice. Oncology|January 21, 2009
Fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia: no country for old men?Terry J Hamblin
Leukemia Research|September 4, 2009
The TCL1 mouse as a model for chronic lymphocytic leukemiaTerry J Hamblin
Pageof 4